Kuo L, Chancellor J D
Department of Medical Physiology, Texas A&M University Health Science Center, College Station 77843-1114, USA.
Am J Physiol. 1995 Aug;269(2 Pt 2):H541-9. doi: 10.1152/ajpheart.1995.269.2.H541.
Coronary microvascular diameter is significantly influenced by adenosine and flow. However, the interaction between these two regulatory mechanisms in the control of coronary microvascular tone remains unknown. Because adenosine can activate ATP-sensitive K+ (KATP) channels and these channels are located on the endothelium in addition to vascular smooth muscle, we hypothesized that adenosine can potentiate flow-induced vasodilation by activating endothelial KATP channels in the coronary microcirculation. To test this hypothesis, experiments were performed in porcine subepicardial coronary arterioles (50-150 microns) using isolated, cannulated vessel techniques to allow intraluminal pressure and flow to be independently controlled. All vessels developed active tone, approximately 67-73% of maximum diameter, at 60 cmH2O intraluminal pressure and showed graded dilation to stepwise increases in flow. The magnitude of flow-induced dilation was potentiated by a threshold dose of adenosine (10(-10) M) but not by nitroprusside (10(-10) M). Luminal application of a high K+ concentration ([K+]) (40 mM) completely blocked flow-induced arteriolar dilation. In addition, luminal glibenclamide (10(-6) M) abolished the adenosine-potentiated component of flow-induced response. Indomethacin (10(-5) M) did not alter the dose-dependent dilation to adenosine. However, endothelial denudation, NG-monomethyl-L-arginine (10(-5) M), and luminal administration of a high [K+] or glibenclamide each produced identical inhibition of adenosine-induced vasodilation by shifting the 50% effective dose to the right by an order of magnitude. In contrast, vasodilation in response to nitroprusside was not altered by these pharmacological interventions.(ABSTRACT TRUNCATED AT 250 WORDS)
冠状动脉微血管直径受腺苷和血流量的显著影响。然而,这两种调节机制在控制冠状动脉微血管张力方面的相互作用仍不清楚。由于腺苷可激活ATP敏感性钾离子(KATP)通道,且这些通道除了位于血管平滑肌外还位于内皮细胞上,我们推测腺苷可通过激活冠状动脉微循环中的内皮KATP通道来增强血流诱导的血管舒张。为验证这一假设,我们采用离体插管血管技术对猪心外膜下冠状动脉小动脉(50 - 150微米)进行实验,以便独立控制管腔内压力和血流量。所有血管在60 cmH2O管腔内压力下均产生主动张力,约为最大直径的67 - 73%,并随流量逐步增加呈分级舒张。阈剂量的腺苷(10^(-10) M)可增强血流诱导的舒张幅度,但硝普钠(10^(-10) M)则无此作用。管腔内施加高钾浓度([K+])(40 mM)可完全阻断血流诱导的小动脉舒张。此外,管腔内应用格列本脲(10^(-6) M)可消除腺苷增强的血流诱导反应成分。吲哚美辛(10^(-5) M)未改变对腺苷的剂量依赖性舒张。然而,内皮剥脱、N - 单甲基 - L - 精氨酸(10^(-5) M)以及管腔内给予高[K+]或格列本脲,均通过将50%有效剂量右移一个数量级,对腺苷诱导的血管舒张产生相同程度的抑制。相比之下,这些药理干预并未改变对硝普钠的血管舒张反应。(摘要截短至250字)